2181-04-6 = 976-71-6 [标题:Reaction Conditions 标题:Fluorine-Substituted Corticosteroids: Synthesis And Evaluation As Potential Receptor-Based Imaging Agents For Positron Emission Tomography Of The Brain 作者:Pomper,Martin G.; Kochanny,Monica J.; Thieme,Andrea M.; Carlson,Kathryn E.; Vanbrocklin,Henry F.; Et Al 参考文献:Nuclear Medicine And Biology 日期:1992 卷标:19(4) 页码:461-80]
13934-61-7 = 976-71-6 反应条件:1.1 Reagents: Dess-Martin Periodinane Solvents: Dichloromethane; 0 °C; 4 H,Rt1.2 Reagents: Sodium Thiosulfate Solvents: Water; Rt1.3 Reagents: Chloranil Solvents: Tert-Butanol; Rt; 3 H,80 °C 标题:One-Pot γ-Lactonization Of Homopropargyl Alcohols Via Intramolecular Ketene Trapping 作者:Yamane,Daichi; Tanaka,Haruna; Hirata,Akihiro; Tamura,Yumiko; Takahashi,Daichi; Et Al 参考文献:Organic Letters 日期:2021 卷标:23(7) 页码:2831-2835]
105-53-3 + 53866-24-3 = 976-71-6 反应条件:1.1 Reagents: Sodium Ethoxide,Monopotassium Phosphate Solvents: Ethanol; 0.3 H,78 °C1.2 4 H,78 °C1.3 Reagents: Acetic Acid; Ph 81.4 Reagents: Water1.5 Reagents: Water; 24 H,100 °C 标题:Simple Cost-Effective Preparation Method Of Canrenone With High Yield And Purity 参考文献:China]
= 976-71-6 反应条件:1.1 Solvents: Ethylene Glycol,Water; 50 °C -> 90 °C 标题:Method For Synthesizing Canrenone 参考文献:China]
20802-57-7 = 976-71-6 反应条件:1.1 Reagents: 1,3-Dibromo-5,5-Dimethylhydantoin,N-Bromosuccinimide Solvents: Acetone,Water1.2 Reagents: Lithium Carbonate (Li2Co3),Lithium Bromide Solvents: Dimethylformamide 标题:Method Of Synthesis Of γ-Lactone 3 Of (7α-Acetylthio-17β-Hydroxy-3-Oxoandrost-4-Ene-17α-Yl)Propionic Acid 参考文献:Russian Federation]
2649-76-5 = 976-71-6 反应条件:1.1 Reagents: 1,3-Dibromo-5,5-Dimethylhydantoin,Sodium Dithionate,Hydrogen Bromide Solvents: 2-Methylpyridine,N-Methyl-2-Pyrrolidone,Water; -10 - -15 °C; 1.5 - 2 H,-10 °C; 1.5 - 2 H,-10 °C1.2 Solvents: Water; 2 H,0 °C1.3 Reagents: Lithium Bromide; 90 - 95 °C; 95 °C -> 40 °C; 2 H,Rt1.4 Reagents: Acetic Acid,Potassium Hydroxide,Hydrochloric Acid Solvents: Water; 40 - 50 °C; 50 °C -> 80 °C 标题:An Improved Process For The Preparation Of Canrenone And Its Intermediate 参考文献:India]
= 976-71-6 反应条件:1.1 Reagents: Calcium Carbonate,Calcium Bromide Solvents: Dimethylformamide,Dichloromethane; 95 °C; 1.5 H,95 °C 标题:Dehydrogenation Method For Preparing Canrenone By Bromination With N-Bromosuccinimide And Debromination With Calcium Bromide And Calcium Carbonate 参考文献:China
专利号:US-2009325918-A1 优先权日:2008-06-16 标 题:Synthesis and separation of optically active isomers and cyclopropyl derivatives of spironolactone and their biological action 发明人:SOMBERG JOHN C; RANADE VASSANT V 权利人:SOMBERG JOHN C; RANADE VASSANT V 摘要:Methods for separation and synthesis of the optically active 7-thioester isomers and mono or bis-cyclopropyl derivatives of spironolactone are provided. Preferred stereoisomerically purified 7-thioester isomers and mono or bis-cyclopropyl derivatives of spironolactone have fewer effects mediated by gonadal steroid receptors relative to effect mediated by minteralocorticoid progesterone receptors, compared to the stereoisomerically unpurified form of the compound. These optically active compounds can be useful for obtaining reduction in moderate essential hypertension and it the treatment of congestive heart failure in humans with minimized undesirable side effects such as gynecomastia, tender breast enlargement and menstrual irregularities in women, and loss of libido in men.
专利号:KR-20100038297-A 优先权日:2007-07-04 标题:Synthesis method of 9α-hydroxy-steroid
1: Derosa G, Maffioli P, D'Avino M, Sala C, Mugellini A, Vulpis V, Felis S, Guasti L, Sarzani R, Bestetti A, Vanasia M, Gaudio G; ESCAPE-IT Trial Investigators group.. Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trial. Cardiovasc Ther. 2017 Feb;35(1):47-54. doi: 10.1111/1755-5922.12235. doi: 10.3109/07853890.2014.969303. Epub 2014 Oct 16. doi: 10.1517/14656566.2014.874415. Epub 2014 Jan 13. doi: 10.1517/14656566.2013.832756. Epub 2013 Aug 28. doi: 10.1517/14656566.2014.896901. Epub 2014 Mar 11. doi: 10.1002/jcla.21501. doi: 10.1111/j.1365-2125.2012.04257.x. 8: DeFrance A, Armbruster D, Petty D, Cooper KC, Dasgupta A. Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common metabolite canrenone. Ther Drug Monit. 2011 Feb;33(1):128-31. doi: 10.1097/FTD.0b013e3181fd4c30. doi: 10.1155/2011/917232. Epub 2011 Dec 13. 10: Knights KM, Bowalgaha K, Miners JO. Spironolactone and canrenone inhibit UGT2B7-catalyzed human liver and kidney microsomal aldosterone 18beta-glucuronidation: a potential drug interaction. Drug Metab Dispos. 2010 Jul;38(7):1011-4. doi: 10.1124/dmd.110.032870. Epub 2010 Mar 19. . Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: the AREA-in-CHF study. Nutr Metab Cardiovasc Dis. 2011 Oct;21(10):783-91. doi: 10.1016/j.numecd.2010.02.012. Epub 2010 Jun 17. doi: 10.1002/jcla.20421. doi: 10.3275/6299. Epub 2009 May 21. doi: 10.1111/j.1476-5381.2009.00329.x. Epub 2009 Aug 6.
合成参考文献
摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664 摘要:HANSCH,C ET AL. (1995) 参考文献:10.1714/643.7495 摘要:Boccanelli A, Agostoni P. [The EMPHASIS-HF study]. G Ital Cardiol (Rome). 2011 May;12(5):315–8. doi: 10.1714/643.7495. 参考文献:10.1186/s12906-020-03042-y 摘要:Hsueh T, Tsai T. Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone. BMC Complementary Medicine and Therapies. 2020 Aug 15;20(1):253. doi: 10.1186/s12906-020-03042-y.